Investors

Slide
Investors
Apple Tree Partners
Biolojic Design

Aulos Co-founders

Aulos was co-founded by Biolojic Design and ATP, with $40 million in Series A funding from ATP. The company is led by pioneers in the field of artificial intelligence, antibody development and cancer immunotherapies.

Antibody icon

Our lead asset, AU-007, is a potential best-in-class, wholly owned IL-2 investigational product that is unlike any other IL-2 therapeutic.

LEARN MORE   →